Search arXivSearch

arXiv · 2602.16111

Calibrate Globally, Measure Everywhere: Scaling LLM-Based Prevalence Measurement Across A/B Experiments

Abstract

Online media platforms track the share of impressions associated with content attributes, or prevalence, to evaluate trade-offs and set guardrails in A/B experiments. LLM-based labeling provides a high-fidelity reference measurement, but is cost-prohibitive to run per experiment, per arm, per segment, and per day on a platform with hundreds of concurrent experiments. We describe a surrogate-based prevalence measurement system deployed in Pinterest's experimentation platform. The contribution is system-level rather than estimator-level: the system maintains a single global calibration of ML score buckets, continuously refreshed from a recurring LLM-labeled stream, and reuses the resulting bucket-level prevalences across every experiment via a per-experiment SQL metric and a delta-focused dashboard. Because the calibration is derived from the platform's daily-batch prevalence samples, it remains representative of production traffic as distributions drift, and in Pinterest's deployment it incurs zero incremental labeling cost. Teams without such infrastructure can instantiate the same pattern with a recurring calibration-labeling workflow whose cost is amortized across all downstream experiments rather than paid per experiment, arm, segment, and day. The system serves ~100 experiments and ~250 arms per day across six calibrated content categories, including a holdout program. Relative to per-experiment LLM labeling, which in practice yields a one-shot read per arm on a small subset of experiments, the surrogate provides daily per-arm prevalence on over 20$\times$ as many concurrent arms under the same labeling budget. Across roughly 300 production audits, the surrogate's 95\% confidence interval contains the LLM-based reference point estimate in 92\% of evaluations, and day-level delta aggregation recovers 2--5\% relative shifts that no single per-arm LLM measurement can detect.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Zehao Xu, Tony Paek, Kevin O'Sullivan, Attila Dobi. 2026-07-29. Calibrate Globally, Measure Everywhere: Scaling LLM-Based Prevalence Measurement Across A/B Experiments. https://arxiv.org/abs/2602.16111

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

Relegation, promotion and the components of scoring in water polo

Relegation, not the championship, decides the outcome of many European water polo leagues: one club has won every recent national title in Italy, Spain and Hungary. We make the relegation decision our object of inference. Serie A1 relegates one club for finishing last and a second through a three-match play-out, and we ask at each stage how much can be known and when. Promoted clubs arrive with no top-flight record, so we also compare four ways of setting their prior. These analyses rest on the first Bayesian hierarchical model of water polo, which splits scoring into even-strength, man-up and penalty components, models opportunities and conversions separately, and lets abilities evolve between seasons. Treating the components as independent proves untenable, since they compete for a common budget of possessions. Fitted to a new dataset of 940 matches, the model identifies the directly relegated club from the ninth round, before the league table does, predicts the play-out field better than the table, and shows the play-out itself to be close to a coin toss. Promoted clubs start below the league on every component except drawing exclusions: knowing a club was promoted improves forecasts; knowing how does not.

stat.AP

Geospatial Foundation Models Capture Health-Relevant Dimensions of Place Beyond Conventional Social Risk Indices

Area-based social risk indices summarize residents' socioeconomic conditions but incompletely capture physical features of place that may affect health. We evaluated whether numerical representations of physical place produced by four geospatial foundation model families from 2022 satellite data explained residual variance in tract-level associations between the Area Deprivation Index, Social Deprivation Index, and Social Vulnerability Index with health outcomes. We used LightGBM to predict variables from the American Community Survey and 40 chronic disease and health-behavior outcomes from CDC PLACES across 82,646 census tracts in the contiguous United States, evaluating performance across 10 held-out states. Among survey variables, models were moderately predictive of some variables including housing type (R-squared up to 0.54) but weak for disability, unemployment, and income disparity. For health outcomes, models explained up to 54% of variance left unexplained by social risk indices, with the largest gains for annual checkups, arthritis, and high blood pressure. Mean total variance explained by geospatial foundation models across the 40 health-related outcomes increased from 0.31 in the smallest tract-size decile to 0.39 in the largest. Geospatial foundation models capture health-relevant features of place not represented by conventional social risk indices and may usefully augment them in epidemiological analyses.

stat.AP

Transporting summary measures of relative effects from randomised trials to the treated patient population: an application to breast cancer endocrine therapy

Randomised trials often report relative treatment effects, such as risk ratios and hazard ratios, for trial populations. Clinical decision-making, however, often benefits from estimates of absolute treatment effects in the population eligible for treatment. Trial participants may not represent this target population well, and restrictions on access to individual participant trial data can further complicate absolute effect estimation. Routine care data are often representative of the target population but may be subject to uncontrolled confounding. We consider estimation of the average treatment effect on the treated (ATT), an absolute measure, by combining a representative sample of treated routine care patients with summary measures (i.e., estimated risk or hazard ratios) from either a randomised trial or a meta-analysis of trials. Under marginal or conditional transportability assumptions, the ATT is shown to be identifiable. The implications of collapsibility of the effect measure on transportability are discussed, and plug-in estimators of the ATT are presented. Simulation studies are used to assess finite sample performance of the estimators in a range of settings. The proposed methods are applied to estimate the ATT of endocrine therapy on 15-year breast cancer mortality using results from a meta-analysis of randomised trials and England's National Disease Registration Service.

stat.AP